Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filing Details

Document Details

Form
Filing Date
Feb 14, 2019
Document Date
Feb 14, 2019
Form Description
Securities offered to employees pursuant to employee benefit plans
Filing Group
Registration Statements
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS, INC.